Kathleen Wilson-Edell, PhD

Title(s)Sr Officer Engmt and Opp Dev, Innovation Ventures
SchoolChancellor/EVC/FAS
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Cornell UniversityA.B.2004Biology
    Yale UniversityPh.D.2009Genetics

    Collapse Overview 
    Collapse Overview
    Kathy joined the UCSF Office of Technology Management(OTM) in March of 2014. She works with UCSF faculty members to protect intellectual property arising from their research and negotiates licenses to these technologies with both startups and established companies.

    Prior to joining OTM full-time, Kathy was a part-time Technology Analyst with UCSF OTM while completing her postdoctoral training at the Buck Institute for Research on Aging in Dr. Christopher Benz’s laboratory. Her postdoctoral research focused on the role of ribosomal proteins in breast cancer. She received her Ph.D. in Genetics from Yale University in Dr. David Stern’s laboratory, studying regulation of gene expression and cytoskeleton rearrangement by BRCA1-related proteins. Kathy’s A.B. is from Cornell University, where she was a Presidential Research Scholar.

    Kathy is passionate about helping UCSF investigators move their discoveries from the laboratory to the public domain.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Author Correction: MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol. 2021 May; 23(5):564-565. Laberge RM, Sun Y, Orjalo AV, Patil CK, Freund A, Zhou L, Curran SC, Davalos AR, Wilson-Edell KA, Liu S, Limbad C, Demaria M, Li P, Hubbard GB, Ikeno Y, Javors M, Desprez PY, Benz CC, Kapahi P, Nelson PS, Campisi J. PMID: 33824512.
      View in: PubMed   Mentions: 4     Fields:    
    2. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol. 2015 Aug; 17(8):1049-61. Laberge RM, Sun Y, Orjalo AV, Patil CK, Freund A, Zhou L, Curran SC, Davalos AR, Wilson-Edell KA, Liu S, Limbad C, Demaria M, Li P, Hubbard GB, Ikeno Y, Javors M, Desprez PY, Benz CC, Kapahi P, Nelson PS, Campisi J. PMID: 26147250; PMCID: PMC4691706.
      View in: PubMed   Mentions: 545     Fields:    Translation:HumansAnimalsCells
    3. RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. Oncotarget. 2014 Jul 15; 5(13):5165-76. Wilson-Edell KA, Kehasse A, Scott GK, Yau C, Rothschild DE, Schilling B, Gabriel BS, Yevtushenko MA, Hanson IM, Held JM, Gibson BW, Benz CC. PMID: 24970821; PMCID: PMC4148130.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    4. mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms. Breast Cancer Res Treat. 2014 Apr; 144(2):287-298. Wilson-Edell KA, Yevtushenko MA, Rothschild DE, Rogers AN, Benz CC. PMID: 24562770; PMCID: PMC4318538.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    5. NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53. Mol Cancer Res. 2011 Jun; 9(6):766-81. Wilson KA, Colavito SA, Schulz V, Wakefield PH, Sessa W, Tuck D, Stern DF. PMID: 21551225; PMCID: PMC3901581.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    6. NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway. Cell Cycle. 2008 Nov 15; 7(22):3584-94. Wilson KA, Stern DF. PMID: 19001859; PMCID: PMC2763172.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    7. Intracellular trafficking of vitamin E in hepatocytes: the role of tocopherol transfer protein. J Lipid Res. 2005 Oct; 46(10):2072-82. Qian J, Morley S, Wilson K, Nava P, Atkinson J, Manor D. PMID: 16024914.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    8. Intracellular localization of alpha-tocopherol transfer protein and alpha-tocopherol. Ann N Y Acad Sci. 2004 Dec; 1031:330-1. Qian J, Wilson K, Nava P, Morley S, Atkinson J, Manor D. PMID: 15753160.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    9. Light-responsive subtilisin-related protease in soybean seedling leaves. Plant Physiol Biochem. 2004 Feb; 42(2):125-34. Barnaby NG, He F, Liu X, Wilson KA, Wilson KA, Tan-Wilson A. PMID: 15283128.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    Kathleen's Networks
    Concepts (106)
    Derived automatically from this person's publications.
    _
    Co-Authors (3)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _